Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-κB in colon cancer cell lines

Experimental Cell Research

Volumn 312, Issue 13, 2006, Pages 2433-2442

  Nakagawa, Yoshihito ^a   Akao, Yukihiro ^a  

^a GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

Author keywords

Colon cancer; FHIT; Growth inhibition; Nuclear factor B

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PARTHENOLIDE; SALAZOSULFAPYRIDINE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ANALYTIC METHOD; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; COLON CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRON TRANSPORT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 33745869448     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.04.004     Document Type: Article

References (36)

1. Glover T.W., and Stein C.K. Chromosome breakage and recombination at fragile sites. Am. J. Hum. Genet. 43 (1988) 265-273
2. Glover T.W., Coyle-Morris J.F., Li F.P., Brown R.S., Berger C.S., Gemmill R.M., and Hecht F. Translocation t(3;8)(p14.2;q24.1) in renal cell carcinoma affects expression of the common fragile site at 3p14(FRA3B) in lymphocytes. Cancer Genet. Cytogenet. 31 (1988) 69-73
3. Rassool F.V., McKeithan T.W., Neilly M.E., van Melle E., Espinosa III R., and Le Beau M.M. Preferential integration of marker DNA into the chromosomal fragile site at 3p14: an approach to cloning fragile sites. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 6657-6661
4. Ohta M., Inoue H., Cotticelli M.G., Kastury K., Baffa R., Palazzo J., Siprashvili Z., Mori M., McCue P., Druck T., Croce C.M., and Huebner K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84 (1996) 587-597
5. Pekarsky Y., Zanesi N., Palamarchuk A., Huebner K., and Croce C.M. FHIT: from gene discovery to cancer treatment and prevention. Lancet Oncol. 3 (2002) 748-754
6. Huebner K., and Croce C.M. Cancer and the FRA3B/FHIT fragile locus: it's a HIT. Br. J. Cancer 88 (2003) 1501-1506
7. Sozzi G., Sard L., De Gregorio L., Marchetti A., Musso K., Buttitta F., Tornielli S., Pellegrini S., Veronese M.L., Manenti G., Incarbone M., Chella A., Angeletti C.A., Pastorino U., Huebner K., Bevilaqua G., Pilotti S., Croce C.M., and Pierotti M.A. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res. 57 (1997) 2121-2123
8. Skopelitou A.S., Katsanos K.H., Michail M., Mitselou A., and Tsianos E.V. Immunohistochemical expression of FHIT gene product in inflammatory bowel disease: significance and correlation with clinicopathological data. Eur. J. Gastroenterol. Hepatol. 15 (2003) 665-673
9. Skopelitou A.S., Mitselou A., Katsanos K.H., Alexopoulou V., and Tsianos E.V. Immunohistochemical expression of Fhit protein in Helicobacter pylori related chronic gastritis, gastric precancerous lesions and gastric carcinoma: correlation with conventional clinicopathologic parameters. Eur. J. Gastroenterol. Hepatol. 15 (2003) 515-523
10. Morikawa H., Nakagawa Y., Hashimoto K., Niki M., Egashira Y., Hirata I., Katsu K., and Akao Y. Frequent altered expression of fragile histidine triad protein in human colorectal adenomas. Biochem. Biophys. Res. Commun. 278 (2000) 205-210
11. Trapasso F., Krakowiak A., Cesari R., Arkles J., Yendamuri S., Ishii H., Vecchione A., Kuroki T., Bieganowski P., Pace H.C., Huebner K., Croce C.M., and Brenner C. Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1592-1597
12. Sevignani C., Calin G.A., Cesari R., Sarti M., Ishii H., Yendamuri S., Vecchione A., Trapasso F., and Croce C.M. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines. Cancer Res. 63 (2003) 1183-1187
13. Baril E.F., Coughlin S.A., and Zamecnik P.C. 5′,5‴-P1, P4 diadenosine tetraphosphate (Ap4A): a putative initiator of DNA replication. Cancer Invest. 3 (1985) 465-471
14. Ishiguro H., Yasuda K., Ishii N., Ihara K., Ohkubo T., Hiyoshi M., Ono K., Senoo-Matsuda N., Shinohara O., Yosshii F., Murakami M., Hartman P.S., and Tsuda M. Enhancement of oxidative damage to cultured cells and Caenorhabditis elegans by mitochondrial electron transport inhibitors. IUBMB Life 51 (2001) 263-268
15. Yamamoto T., Maruyama W., Kato Y., Yi H., Shamoto-Nagai M., Tanaka M., Sato Y., and Naoi M. Selective nitration of mitochondrial complex I by peroxynitrite: involvement in mitochondria dysfunction and cell death of dopaminergic SH-SY5Y cells. J. Neural. Transm. 109 (2002) 1-13
16. Lee M.H., Hyun D.H., Jenner P., and Halliwell B. Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production. J. Neurochem. 78 (2001) 32-41
17. Wahl C., Liptay S., Adler G., and Schmid R.M. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J. Clin. Invest. 101 (1998) 1163-1174
18. Hehner S.P., Hofmann T.G., Droge W., and Schmitz M.L. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-κB by targeting the IκB kinase complex. J. Immunol. 163 (1999) 5617-5623
19. Nakagawa Y., Iinuma M., Matsuura N., Yi K., Naoi M., Nakayama T., Nozawa Y., and Akao Y. A potent apoptosis-inducing activity of a sesquiterpene lactone, arucanolide, in HL60 cells: a crucial role of apoptosis-inducing factor. J. Pharmacol. Sci. 97 (2005) 242-252
20. Nakagawa Y., Akao Y., Morikawa H., Hirata I., Katsu K., Naoe T., Ohishi N., and Yagi K. Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines. Life Sci. 70 (2002) 2253-2269
21. Akao Y., Mizoguchi H., Ohishi N., and Yagi K. Growth inhibition by overexpression of human DEAD box protein rck/p54 in cells of a guinea pig cell line. FEBS Lett. 429 (1998) 279-283
22. Pace H.C., Garrison P.N., Robinson A.K., Barnes L.D., Draganescu A., Rosler A., Blackburn G.M., Siprashvili Z., Croce C.M., Huebner K., and Brenner C. Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 5484-5489
23. Tsujimoto Y., and Shimizu S. bcl-2 family: life-or-death switch. FEBS Lett. 466 (2000) 6-10
24. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
25. Pap M., and Cooper G.M. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J. Biol. Chem. 273 (1998) 19929-19932
26. Mukhopadhyay A., Manna S.K., and Aggarwal B.B. Pervanadate-induced nuclear factor-κB activation requires tyrosine phosphorylation and degradation of IκBα. J. Biol. Chem. 275 (2000) 8549-8555
27. Hughes G., Murphy M.P., and Ledgerwood E.C. Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor κB to modulate tumour necrosis factor-induced apoptosis: evidence from mitochondria-targeted antioxidants. Biochem. J. 389 (2005) 83-89
28. nA), a novel class of signalling molecules?. FEBS Lett. 427 (1998) 157-163
29. Murphy G.A., Halliday D., and McLennan A.G. The Fhit tumor suppressor protein regulates the intracellular concentration of diadenosine triphosphate but not diadenosine tetraphosphate. Cancer Res. 60 (2000) 2342-2344
30. Guo J., Verma U.N., Gaynor R.B., Frenkel E.P., and Becerra C.R. Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit. Clin. Cancer Res. 10 (2004) 3333-3341
31. Tegethoff S., Behlke J., and Scheidereit C. Tetrameric oligomerization of IκB kinaseγ (IKKγ) is obligatory for IKK complex activity and NF-κB activation. Mol. Cell. Biol. 23 (2003) 2029-2041
32. Chen Z., Hagler J., Palombella V.J., Melandri F., Scherer D., Ballard D., and Maniatis T. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes. Dev. 9 (1995) 1586-1597
33. Maness P.F., Perry M.E., and Levy B.T. P1,P4-Di(adenosine-5′)tetraphosphate inhibits phosphorylation of immunoglobulin G by Rous sarcoma virus pp60src. J. Biol. Chem. 258 (1983) 4055-4058
34. Oda Y., Kuo M.D., Huang S.S., and Huang J.S. The major acidic fibroblast growth factor (aFGF)-stimulated phosphoprotein from bovine liver plasma membranes has aFGF-stimulated kinase, autoadenylylation, and alkaline nucleotide phosphodiesterase activities. J. Biol. Chem. 268 (1993) 27318-27326
35. Shi Y., Zou M., Farid N.R., and Paterson M.C. Association of FHIT (fragile histidine triad), a candidate tumour suppressor gene, with the ubiquitin-conjugating enzyme hUBC9. Biochem. J. 352 (2000) 443-448
36. Golebiowski F., Szulc A., Szutowicz A., and Pawelczyk T. Ubc9-induced inhibition of diadenosine triphosphate hydrolase activity of the putative tumor suppressor protein Fhit. Arch. Biochem. Biophys. 428 (2004) 160-164